newsfilter
← Latest News
GlobeNewswire·

Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program

TORONTO, July 17, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (TSXV:ARCH, OTCQB:ACHFF) today announced that it has engaged a U.S.-based laboratory specializing in bioengineering to accelerate the Company’s pre-IND